The Phia Group Blog

By The Phia Group Prescription drug costs remain one of the biggest pressure points for self-funded health plans. GLP-1s, specialty drugs, gene therapies, biologics, rebate arrangements, PBM transparency, and Medicare drug pricing reforms all tend to dominate the conversation. But…

By David Ostrowsky For the second consecutive July 4th weekend, a seismic healthcare development has unfolded. A year ago, the newly-introduced One Big Beautiful Bill Act (OBBA) ushered in a wave of healthcare changes. This year, as Americans were firing…

By: Rhys Cundiff, Esq. Health plan administrators and recovery professionals spend a great deal of time pursuing reimbursement from traditional third-party recoveries arising from motor vehicle accidents, premises liability claims, medical malpractice cases, and similar actions. But what happens when…

By: Kelly Dempsey, Esq. and David Ostrowsky On February 26, 2026, the U.S. Department of Labor (DOL) unveiled a proposed rule to change the means by which independent contractor status is determined per the Fair Labor Standards Act (FLSA). The…

By: Stewart P. Miller, Esq. Routine subrogation negotiations frequently borrow tactics from ERISA litigation. One common example is the use of document requests under ERISA § 104(b)(4), 29 U.S.C. § 1024(b)(4), as leverage in reimbursement discussions. For plans, TPAs, and…

By: David Ostrowsky From the second our iPhone alarms blast off in the morning, we remain hooked on our smartphones. Throughout the day, our apps take us to the Middle East, Wall Street, and Outer Space. Our finances, errand schedule,…